A phase 1 study of CS 5006 for solid tumors
Latest Information Update: 30 Aug 2024
Price :
$35 *
At a glance
- Drugs CS 5006 (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 30 Aug 2024 New trial record
- 23 Aug 2024 According to CStone media release, IND submissions expected in 2025.